Christopher J. White, DO, MD

Arnold H. Seto , MD, MPA, CCDS, FACC, FSCAI;

Conversations in Cardiology: Should You Still Prepare the Femoral Site for Radial Cases?

Michael J. Lim , MD;

When is high risk too high? Dr. Morton Kern and six expert colleagues review the complexity of left main percutaneous coronary intervention (PCI) in a lab without on-site surgery.

When is high risk too high? Dr....

03/14/2023

Cath Lab Digest

04/30/2015

David J. Cohen , MD, MPH, MSc;

Robert J. Applegate , MD;

Ajay J. Kirtane , MD, SM;

Peter Ver Lee , MD;

David E. Kandzari , MD;

Mauricio G. Cohen , MD, FACC;

Samuel M. Butman , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Aaron V. Kaplan ;

Prashant Kaul , MD, FACC, FSCAI;

Malcolm R. Bell , MD;

Mladen I. Vidovich , MD;

Left Main PCI in Interventional Labs Without On-Site Surgery: When is High Risk Too High?

John Hodgson , MD, FSCAI, FACC;

Michael Krucoff ;

Ramon Quesda ;

Fred Resnick ;

Gus Pichard, Washington Heart Center, asks, “Mort, who among the radialists has stopped shaving the groin?

Gus Pichard, Washington Heart...

04/30/2015

Cath Lab Digest

Clinical Editor's Corner

02/16/2023

Hurry, It’s a STEMI! But How Quick is Too Quick for Safety?

The issue of what constitutes safe practice in the no-SOS labs is not trivial. Before I present a summary of the revised consensus statement, I thought I would stimulate our thinking by providing a real case from our lab, what my colleagues...

The issue of what constitutes...

02/16/2023

Cath Lab Digest

07/31/2013

David R. Holmes Jr., MD;

E. Magnus Ohman , MD;

Barry F. Uretsky , MD;

Peter B. Berger , MD;

Eric Bates ;

Gregg W. Stone , MD, FACC, FSCAI;

Robert J. Applegate , MD;

Sunil V. Rao , MD, FACC, FSCAI;

Ted Feldman , MD, FSCAI, FACC, FESC;

Conversations in Cardiology: Is There Value in Post-PCI Troponin Measurements?

I asked my expert cath lab colleagues to weigh in on this issue with 3 quick answers on whether forced reduction of D2B time is 1) beneficial for the patient or 2) the hospital or 3) the interventionalist, and if you have time, a short...

I asked my expert cath lab...

07/31/2013

Cath Lab Digest

Clinical Editor's Corner

01/03/2023

Duane S. Pinto , MD, MPH;

Timothy D. Henry , MD;

Neal S. Kleiman , MD;

Samuel M. Butman , MD;

David G. Rizik , MD, FACC, FSCAI;

Gurpreet S. Sandhu , MD, PhD;

Rajiv Gulati , MD, PhD;

Dean J. Kereiakes , MD, FACC, FSCAI;

Jeffrey W. Moses , MD;

Srihari S. Naidu , MD;

Peter L. Duffy , MD, MMM, FACC, FSCAI;

What Should We Do With an Anomalous Coronary Artery (ALCA) With a Malignant Left Main Course in an Asymptomatic Patient?

Ajay J. Kirtane , MD, SM;

If we don’t make changes in patient care after PCI regardless of the troponin level, is there any value in ordering it?

If we don’t make changes in...

01/03/2023

Cath Lab Digest

Clinical Editor's Corner

05/07/2018

Michael J. Lim , MD;

John W. Hirshfeld Jr.;

TAVR: Who Should Prep the Device? The Role of Industry Representatives’ Participation in the Cath Lab

George W. Vetrovec , MD;

Jeannie Yu , MD;

Andrew Doorey ;

Pinak Bipin Shah ;

Jeffrey W. Moses , MD;

Paul S. Teirstein , MD, FACC;

William M. Suh , MD;

David E. Kandzari , MD;

Dr. Paul Teirstein, Chief of Cardiology, at Scripps Clinic, La Jolla, California, asked our cath lab experts for their opinions on what to do with an asymptomatic executive who had a screening CTA (Figure 1).

Dr. Paul Teirstein, Chief of...

05/07/2018

Cath Lab Digest

Clinical Editor's Corner

01/03/2022

Michael Ragosta , MD;

David J. Cohen , MD, MPH, MSc;

Ramon Quesada , MD, FACP, FACC, FSCAI;

Susheel K. Kodali , MD;

Stephen R. Ramee , MD;

Samuel M. Butman , MD;

Amir Kaki , MD, FACC, FSCAI;

Duane S. Pinto , MD, MPH;

William F. Fearon , MD;

Mauricio G. Cohen , MD, FACC;

Robert J. Applegate , MD;

Aaron V. Kaplan ;

David G. Rizik , MD, FACC, FSCAI;

Jeffrey Marshall ;

Conversations in Cardiology – Does Every Primary PCI Lab Need an Impella* (or Its Equivalent)?

After years of having the industry clinical support staff prep the transcatheter aortic valve replacement (TAVR) valves in the lab (without a single adverse event because of faulty prep, to my knowledge) some administrators have now begun to...

After years of having the...

01/03/2022

Cath Lab Digest

Clinical Editor's Corner

07/26/2016

Aaron V. Kaplan ;

Lloyd W. Klein , MD;

Gurpreet S. Sandhu , MD, PhD;

Gregg W. Stone , MD, FACC, FSCAI;

Peter B. Berger , MD;

David E. Kandzari , MD;

George W. Vetrovec , MD;

Ted Feldman , MD, FSCAI, FACC, FESC;

Jim Blankenship , MD;

Navin Kumar Kapur , MD;

Conversations in Cardiology: The End of End-hole Left Ventriculography – A Consensus of Operators

Jeffrey W. Moses , MD;

Ajay J. Kirtane , MD, SM;

Steven R. Bailey , MD;

In this “Conversation in Cardiology”, Dr. Ted Feldman from Evanston Hospital, Evanston, Illinois, asks, “Is the availability of Impella a requirement for every STEMI [ST-elevation myocardial infarction] program (even in lower volume programs...

In this “Conversation in...

07/26/2016

Cath Lab Digest

Clinical Editor's Corner

11/14/2013

Joseph D. Babb , MD;

George W. Vetrovec , MD;

John Bittl , MD;

Lloyd W. Klein , MD;

Allen Jeremias , MD, MSc;

Gregg W. Stone , MD, FACC, FSCAI;

Steven R. Bailey , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Frederick G.P. Welt , MD;

David G. Rizik , MD, FACC, FSCAI;

Mladen I. Vidovich , MD;

Charles E. Chambers , MD;

Puzzling Erythematous Patches Managed with Anakinra

Barry F. Uretsky , MD;

Peter Ver Lee , MD;

Mitchell W. Krucoff , MD;

Bernard DeBruyne ;

Kirk N. Garrett ;

Carl L. Tommaso , MD;

Malcolm R. Bell , MD;

Left ventriculography, once an integral part of every cardiac angiographic procedure, has been reconsidered as often unnecessary in light of high quality echocardiography for left ventricular (LV) functional assessment.

Left ventriculography, once an...

11/14/2013

Cath Lab Digest

Feature Story

07/11/2021